Use of docetaxel and carboplatin for patients with non-small-cell lung cancer

ONCOLOGY

Volumn 11, Issue 7 SUPPL., 1997, Pages 31-33

  Belani, Chandra P ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; DOCETAXEL;

ADULT; AGED; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MIXTURE; DRUG TOLERANCE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; SURVIVAL RATE; TREATMENT PLANNING;

EID: 0030794978     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (19)

1. Marino P, Pampalloona S, Preatoni, P, et al: Chemotherapy vs supportive care in non-small-cell lung cancer: Results of a meta-analysis of the literature. Chest 106:861-865, 1994.
2. Rapp E, Pater JL, Willan A, et al: Chemotherapy can prolong survival in patients with advanced non-small cell lung cancer: Report of a Canadian multicenter randomized trial. J Clin Oncol 6:633-641, 1988.
3. Ganz PA, Figlin RA, Haskell CM, et al: Supportive care versus supportive care and combination chemotherapy in metastatic non-small cell lung cancer. CA Cancer J Clin 63:1271-1278, 1989.
4. Woods RL, Williams CJ, Levi J, et al: A randomized trial of cisplatin and vindesine versus supportive care only in advanced non-small cell lung cancer. Br J Cancer 61:608-611, 1990.
5. Cellerino R, Tummarello D, Guidi F, et al: A randomized trial of alternating chemotherapy versus best supportive care in advanced non-small cell lung cancer. J Clin Oncol 9:387-395, 1985.
6. Quoix E, Dietemann A, Charbonneau J, et al: La chimiothérapie comportant du cisplatine est-elle utile dans le cancer bronchique non microcellulaire au stade IV? Résultats d' une étude randomisée. Bull Cancer 78:341-346, 1991.
7. Kaasa S, Lund E, Thorud E, et al: Symptomatic treatment versus combination chemotherapy for patients with extensive non-small cell lung cancer. CA Cancer J Clin 67:2443-2447, 1991.
8. Rigas JR: Docetaxel in stage III and IV non-small cell lung cancer. Eur J Cancer 31A(suppl 4):S-18-S20, 1995.
9. Bonomi PD, Finkelstein DM, Ruckdeschel JC, et al: Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: A study of the Eastern Cooperative Oncology Group. J Clin Oncol 7:1602-1613, 1989.
10. Gueritte-Voegelein F, Guenard D, Lavelle F, et al: Relationships between the structure of taxol analogues and their antimitotic activity. J Med Chem 34:992-998, 1991.
11. Ringel I, Horwitz SB Studies with RP 56976 (Taxotere): A semisynthetic analogue of taxol. J Natl Cancer Inst 83:288-291, 1991.
12. Cortes JE, Pazdur R: Docetaxel. J Clin Oncol 13:2643-2655, 1995.
13. Calvert AH, Harland SJ, Newell DR, et al: Early clinical studies with cis-diammine-1, 1 cyclobutane-decarboxylate platinum II. Cancer Chemother Pharmacol 9:140-147, 1982.
14. Curt GA, Grygeil JJ, Corden BJ, et al. A phase I and pharmacokinetic study of diammine-cyclobutane-decarboxylate-platinum (NSC 241240). Cancer Res 43:4470-4473, 1983.
15. Egorin MJ, Van Echo DA, Tipping SJ, et al: Pharmacokinetics and dosage reduction of cis-diammine (1,1-cyclobutane di-carboxylate) platinum in patients with impaired renal function. Cancer Res 44:5432-5438, 1984.
16. Calvert AH, Newell DR, Gumbrell LA, et al: Carboplatin dosage: Prospective evaluation of a simple formula based on renal function. J Clin Oncol 7:1748-1756, 1989.
17. Egorin MJ, Van Echo DA, Olman EA, et al: Prospective validation of a pharmacologically based dosing schema for the cis- diammmedichloroplatinum (II) analogue diammine cyclobutanedicarboxylatoplatinum. Cancer Res 45:6502-6506, 1985.
18. Belani CP, Egorin MJ, Abrams JS, et al: A novel pharmacodynamically based approach to dose optimization of carboplatin when used in combination with etoposide. J Clin Oncol 7:1896-1902, 1989
19. Belani CP, Hadeed V, Ramanathan R, et al: Docetaxel and carboplatin: A phase I and pharmacokinetic trial for advanced non- hematologic malignancies (abstract 771) Proc Am Soc Clin Oncol 16:220, 1997.